1 Study Coverage
1.1 Antiallergic Non-Drug Supplements Product Introduction
1.2 Market by Type
1.2.1 Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Liquids
1.3 Market by Application
1.3.1 Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pollen Allergy
1.3.3 Dust Mites Allergy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antiallergic Non-Drug Supplements Sales Estimates and Forecasts 2017-2028
2.2 Global Antiallergic Non-Drug Supplements Revenue Estimates and Forecasts 2017-2028
2.3 Global Antiallergic Non-Drug Supplements Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antiallergic Non-Drug Supplements Sales by Region
2.4.1 Global Antiallergic Non-Drug Supplements Sales by Region (2017-2022)
2.4.2 Global Sales Antiallergic Non-Drug Supplements by Region (2023-2028)
2.5 Global Antiallergic Non-Drug Supplements Revenue by Region
2.5.1 Global Antiallergic Non-Drug Supplements Revenue by Region (2017-2022)
2.5.2 Global Antiallergic Non-Drug Supplements Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antiallergic Non-Drug Supplements Sales by Manufacturers
3.1.1 Global Top Antiallergic Non-Drug Supplements Manufacturers by Sales (2017-2022)
3.1.2 Global Antiallergic Non-Drug Supplements Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiallergic Non-Drug Supplements in 2021
3.2 Global Antiallergic Non-Drug Supplements Revenue by Manufacturers
3.2.1 Global Antiallergic Non-Drug Supplements Revenue by Manufacturers (2017-2022)
3.2.2 Global Antiallergic Non-Drug Supplements Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antiallergic Non-Drug Supplements Revenue in 2021
3.3 Global Antiallergic Non-Drug Supplements Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antiallergic Non-Drug Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antiallergic Non-Drug Supplements Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antiallergic Non-Drug Supplements Sales by Type
4.1.1 Global Antiallergic Non-Drug Supplements Historical Sales by Type (2017-2022)
4.1.2 Global Antiallergic Non-Drug Supplements Forecasted Sales by Type (2023-2028)
4.1.3 Global Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
4.2 Global Antiallergic Non-Drug Supplements Revenue by Type
4.2.1 Global Antiallergic Non-Drug Supplements Historical Revenue by Type (2017-2022)
4.2.2 Global Antiallergic Non-Drug Supplements Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
4.3 Global Antiallergic Non-Drug Supplements Price by Type
4.3.1 Global Antiallergic Non-Drug Supplements Price by Type (2017-2022)
4.3.2 Global Antiallergic Non-Drug Supplements Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antiallergic Non-Drug Supplements Sales by Application
5.1.1 Global Antiallergic Non-Drug Supplements Historical Sales by Application (2017-2022)
5.1.2 Global Antiallergic Non-Drug Supplements Forecasted Sales by Application (2023-2028)
5.1.3 Global Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
5.2 Global Antiallergic Non-Drug Supplements Revenue by Application
5.2.1 Global Antiallergic Non-Drug Supplements Historical Revenue by Application (2017-2022)
5.2.2 Global Antiallergic Non-Drug Supplements Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
5.3 Global Antiallergic Non-Drug Supplements Price by Application
5.3.1 Global Antiallergic Non-Drug Supplements Price by Application (2017-2022)
5.3.2 Global Antiallergic Non-Drug Supplements Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antiallergic Non-Drug Supplements Market Size by Type
6.1.1 North America Antiallergic Non-Drug Supplements Sales by Type (2017-2028)
6.1.2 North America Antiallergic Non-Drug Supplements Revenue by Type (2017-2028)
6.2 North America Antiallergic Non-Drug Supplements Market Size by Application
6.2.1 North America Antiallergic Non-Drug Supplements Sales by Application (2017-2028)
6.2.2 North America Antiallergic Non-Drug Supplements Revenue by Application (2017-2028)
6.3 North America Antiallergic Non-Drug Supplements Market Size by Country
6.3.1 North America Antiallergic Non-Drug Supplements Sales by Country (2017-2028)
6.3.2 North America Antiallergic Non-Drug Supplements Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antiallergic Non-Drug Supplements Market Size by Type
7.1.1 Europe Antiallergic Non-Drug Supplements Sales by Type (2017-2028)
7.1.2 Europe Antiallergic Non-Drug Supplements Revenue by Type (2017-2028)
7.2 Europe Antiallergic Non-Drug Supplements Market Size by Application
7.2.1 Europe Antiallergic Non-Drug Supplements Sales by Application (2017-2028)
7.2.2 Europe Antiallergic Non-Drug Supplements Revenue by Application (2017-2028)
7.3 Europe Antiallergic Non-Drug Supplements Market Size by Country
7.3.1 Europe Antiallergic Non-Drug Supplements Sales by Country (2017-2028)
7.3.2 Europe Antiallergic Non-Drug Supplements Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antiallergic Non-Drug Supplements Market Size by Type
8.1.1 Asia Pacific Antiallergic Non-Drug Supplements Sales by Type (2017-2028)
8.1.2 Asia Pacific Antiallergic Non-Drug Supplements Revenue by Type (2017-2028)
8.2 Asia Pacific Antiallergic Non-Drug Supplements Market Size by Application
8.2.1 Asia Pacific Antiallergic Non-Drug Supplements Sales by Application (2017-2028)
8.2.2 Asia Pacific Antiallergic Non-Drug Supplements Revenue by Application (2017-2028)
8.3 Asia Pacific Antiallergic Non-Drug Supplements Market Size by Region
8.3.1 Asia Pacific Antiallergic Non-Drug Supplements Sales by Region (2017-2028)
8.3.2 Asia Pacific Antiallergic Non-Drug Supplements Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antiallergic Non-Drug Supplements Market Size by Type
9.1.1 Latin America Antiallergic Non-Drug Supplements Sales by Type (2017-2028)
9.1.2 Latin America Antiallergic Non-Drug Supplements Revenue by Type (2017-2028)
9.2 Latin America Antiallergic Non-Drug Supplements Market Size by Application
9.2.1 Latin America Antiallergic Non-Drug Supplements Sales by Application (2017-2028)
9.2.2 Latin America Antiallergic Non-Drug Supplements Revenue by Application (2017-2028)
9.3 Latin America Antiallergic Non-Drug Supplements Market Size by Country
9.3.1 Latin America Antiallergic Non-Drug Supplements Sales by Country (2017-2028)
9.3.2 Latin America Antiallergic Non-Drug Supplements Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antiallergic Non-Drug Supplements Market Size by Type
10.1.1 Middle East and Africa Antiallergic Non-Drug Supplements Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Type (2017-2028)
10.2 Middle East and Africa Antiallergic Non-Drug Supplements Market Size by Application
10.2.1 Middle East and Africa Antiallergic Non-Drug Supplements Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Application (2017-2028)
10.3 Middle East and Africa Antiallergic Non-Drug Supplements Market Size by Country
10.3.1 Middle East and Africa Antiallergic Non-Drug Supplements Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Costco (Kirkland Signature)
11.1.1 Costco (Kirkland Signature) Corporation Information
11.1.2 Costco (Kirkland Signature) Overview
11.1.3 Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Costco (Kirkland Signature) Recent Developments
11.2 General Nutrition Center
11.2.1 General Nutrition Center Corporation Information
11.2.2 General Nutrition Center Overview
11.2.3 General Nutrition Center Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 General Nutrition Center Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 General Nutrition Center Recent Developments
11.3 Blackmores
11.3.1 Blackmores Corporation Information
11.3.2 Blackmores Overview
11.3.3 Blackmores Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Blackmores Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Blackmores Recent Developments
11.4 Thompson's
11.4.1 Thompson's Corporation Information
11.4.2 Thompson's Overview
11.4.3 Thompson's Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Thompson's Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thompson's Recent Developments
11.5 BY-HEALTH
11.5.1 BY-HEALTH Corporation Information
11.5.2 BY-HEALTH Overview
11.5.3 BY-HEALTH Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BY-HEALTH Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BY-HEALTH Recent Developments
11.6 Healthy Care
11.6.1 Healthy Care Corporation Information
11.6.2 Healthy Care Overview
11.6.3 Healthy Care Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Healthy Care Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Healthy Care Recent Developments
11.7 Emerald Labs
11.7.1 Emerald Labs Corporation Information
11.7.2 Emerald Labs Overview
11.7.3 Emerald Labs Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Emerald Labs Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Emerald Labs Recent Developments
11.8 FANCL Corporation
11.8.1 FANCL Corporation Corporation Information
11.8.2 FANCL Corporation Overview
11.8.3 FANCL Corporation Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 FANCL Corporation Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 FANCL Corporation Recent Developments
11.9 Zahler
11.9.1 Zahler Corporation Information
11.9.2 Zahler Overview
11.9.3 Zahler Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Zahler Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zahler Recent Developments
11.10 VitaTree
11.10.1 VitaTree Corporation Information
11.10.2 VitaTree Overview
11.10.3 VitaTree Antiallergic Non-Drug Supplements Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 VitaTree Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 VitaTree Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antiallergic Non-Drug Supplements Industry Chain Analysis
12.2 Antiallergic Non-Drug Supplements Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiallergic Non-Drug Supplements Production Mode & Process
12.4 Antiallergic Non-Drug Supplements Sales and Marketing
12.4.1 Antiallergic Non-Drug Supplements Sales Channels
12.4.2 Antiallergic Non-Drug Supplements Distributors
12.5 Antiallergic Non-Drug Supplements Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antiallergic Non-Drug Supplements Industry Trends
13.2 Antiallergic Non-Drug Supplements Market Drivers
13.3 Antiallergic Non-Drug Supplements Market Challenges
13.4 Antiallergic Non-Drug Supplements Market Restraints
14 Key Findings in The Global Antiallergic Non-Drug Supplements Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsules
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Liquids
Table 5. Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Antiallergic Non-Drug Supplements Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antiallergic Non-Drug Supplements Sales by Region (2017-2022) & (K Bottles)
Table 8. Global Antiallergic Non-Drug Supplements Sales Market Share by Region (2017-2022)
Table 9. Global Antiallergic Non-Drug Supplements Sales by Region (2023-2028) & (K Bottles)
Table 10. Global Antiallergic Non-Drug Supplements Sales Market Share by Region (2023-2028)
Table 11. Global Antiallergic Non-Drug Supplements Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Antiallergic Non-Drug Supplements Revenue Market Share by Region (2017-2022)
Table 13. Global Antiallergic Non-Drug Supplements Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Antiallergic Non-Drug Supplements Revenue Market Share by Region (2023-2028)
Table 15. Global Antiallergic Non-Drug Supplements Sales by Manufacturers (2017-2022) & (K Bottles)
Table 16. Global Antiallergic Non-Drug Supplements Sales Share by Manufacturers (2017-2022)
Table 17. Global Antiallergic Non-Drug Supplements Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Antiallergic Non-Drug Supplements Revenue Share by Manufacturers (2017-2022)
Table 19. Antiallergic Non-Drug Supplements Price by Manufacturers (2017-2022) &(USD/Bottle)
Table 20. Global Antiallergic Non-Drug Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Antiallergic Non-Drug Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiallergic Non-Drug Supplements as of 2021)
Table 22. Antiallergic Non-Drug Supplements Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Antiallergic Non-Drug Supplements Product Offered
Table 24. Date of Manufacturers Enter into Antiallergic Non-Drug Supplements Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiallergic Non-Drug Supplements Sales by Type (2017-2022) & (K Bottles)
Table 27. Global Antiallergic Non-Drug Supplements Sales by Type (2023-2028) & (K Bottles)
Table 28. Global Antiallergic Non-Drug Supplements Sales Share by Type (2017-2022)
Table 29. Global Antiallergic Non-Drug Supplements Sales Share by Type (2023-2028)
Table 30. Global Antiallergic Non-Drug Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Antiallergic Non-Drug Supplements Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Antiallergic Non-Drug Supplements Revenue Share by Type (2017-2022)
Table 33. Global Antiallergic Non-Drug Supplements Revenue Share by Type (2023-2028)
Table 34. Antiallergic Non-Drug Supplements Price by Type (2017-2022) & (USD/Bottle)
Table 35. Global Antiallergic Non-Drug Supplements Price Forecast by Type (2023-2028) & (USD/Bottle)
Table 36. Global Antiallergic Non-Drug Supplements Sales by Application (2017-2022) & (K Bottles)
Table 37. Global Antiallergic Non-Drug Supplements Sales by Application (2023-2028) & (K Bottles)
Table 38. Global Antiallergic Non-Drug Supplements Sales Share by Application (2017-2022)
Table 39. Global Antiallergic Non-Drug Supplements Sales Share by Application (2023-2028)
Table 40. Global Antiallergic Non-Drug Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Antiallergic Non-Drug Supplements Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Antiallergic Non-Drug Supplements Revenue Share by Application (2017-2022)
Table 43. Global Antiallergic Non-Drug Supplements Revenue Share by Application (2023-2028)
Table 44. Antiallergic Non-Drug Supplements Price by Application (2017-2022) & (USD/Bottle)
Table 45. Global Antiallergic Non-Drug Supplements Price Forecast by Application (2023-2028) & (USD/Bottle)
Table 46. North America Antiallergic Non-Drug Supplements Sales by Type (2017-2022) & (K Bottles)
Table 47. North America Antiallergic Non-Drug Supplements Sales by Type (2023-2028) & (K Bottles)
Table 48. North America Antiallergic Non-Drug Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Antiallergic Non-Drug Supplements Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Antiallergic Non-Drug Supplements Sales by Application (2017-2022) & (K Bottles)
Table 51. North America Antiallergic Non-Drug Supplements Sales by Application (2023-2028) & (K Bottles)
Table 52. North America Antiallergic Non-Drug Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Antiallergic Non-Drug Supplements Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Antiallergic Non-Drug Supplements Sales by Country (2017-2022) & (K Bottles)
Table 55. North America Antiallergic Non-Drug Supplements Sales by Country (2023-2028) & (K Bottles)
Table 56. North America Antiallergic Non-Drug Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Antiallergic Non-Drug Supplements Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Antiallergic Non-Drug Supplements Sales by Type (2017-2022) & (K Bottles)
Table 59. Europe Antiallergic Non-Drug Supplements Sales by Type (2023-2028) & (K Bottles)
Table 60. Europe Antiallergic Non-Drug Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Antiallergic Non-Drug Supplements Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Antiallergic Non-Drug Supplements Sales by Application (2017-2022) & (K Bottles)
Table 63. Europe Antiallergic Non-Drug Supplements Sales by Application (2023-2028) & (K Bottles)
Table 64. Europe Antiallergic Non-Drug Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Antiallergic Non-Drug Supplements Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Antiallergic Non-Drug Supplements Sales by Country (2017-2022) & (K Bottles)
Table 67. Europe Antiallergic Non-Drug Supplements Sales by Country (2023-2028) & (K Bottles)
Table 68. Europe Antiallergic Non-Drug Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Antiallergic Non-Drug Supplements Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Antiallergic Non-Drug Supplements Sales by Type (2017-2022) & (K Bottles)
Table 71. Asia Pacific Antiallergic Non-Drug Supplements Sales by Type (2023-2028) & (K Bottles)
Table 72. Asia Pacific Antiallergic Non-Drug Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Antiallergic Non-Drug Supplements Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Antiallergic Non-Drug Supplements Sales by Application (2017-2022) & (K Bottles)
Table 75. Asia Pacific Antiallergic Non-Drug Supplements Sales by Application (2023-2028) & (K Bottles)
Table 76. Asia Pacific Antiallergic Non-Drug Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Antiallergic Non-Drug Supplements Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Antiallergic Non-Drug Supplements Sales by Region (2017-2022) & (K Bottles)
Table 79. Asia Pacific Antiallergic Non-Drug Supplements Sales by Region (2023-2028) & (K Bottles)
Table 80. Asia Pacific Antiallergic Non-Drug Supplements Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Antiallergic Non-Drug Supplements Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Antiallergic Non-Drug Supplements Sales by Type (2017-2022) & (K Bottles)
Table 83. Latin America Antiallergic Non-Drug Supplements Sales by Type (2023-2028) & (K Bottles)
Table 84. Latin America Antiallergic Non-Drug Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Antiallergic Non-Drug Supplements Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Antiallergic Non-Drug Supplements Sales by Application (2017-2022) & (K Bottles)
Table 87. Latin America Antiallergic Non-Drug Supplements Sales by Application (2023-2028) & (K Bottles)
Table 88. Latin America Antiallergic Non-Drug Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Antiallergic Non-Drug Supplements Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Antiallergic Non-Drug Supplements Sales by Country (2017-2022) & (K Bottles)
Table 91. Latin America Antiallergic Non-Drug Supplements Sales by Country (2023-2028) & (K Bottles)
Table 92. Latin America Antiallergic Non-Drug Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Antiallergic Non-Drug Supplements Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Antiallergic Non-Drug Supplements Sales by Type (2017-2022) & (K Bottles)
Table 95. Middle East and Africa Antiallergic Non-Drug Supplements Sales by Type (2023-2028) & (K Bottles)
Table 96. Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Antiallergic Non-Drug Supplements Sales by Application (2017-2022) & (K Bottles)
Table 99. Middle East and Africa Antiallergic Non-Drug Supplements Sales by Application (2023-2028) & (K Bottles)
Table 100. Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Antiallergic Non-Drug Supplements Sales by Country (2017-2022) & (K Bottles)
Table 103. Middle East and Africa Antiallergic Non-Drug Supplements Sales by Country (2023-2028) & (K Bottles)
Table 104. Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Antiallergic Non-Drug Supplements Revenue by Country (2023-2028) & (US$ Million)
Table 106. Costco (Kirkland Signature) Corporation Information
Table 107. Costco (Kirkland Signature) Description and Major Businesses
Table 108. Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 109. Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Costco (Kirkland Signature) Recent Developments
Table 111. General Nutrition Center Corporation Information
Table 112. General Nutrition Center Description and Major Businesses
Table 113. General Nutrition Center Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 114. General Nutrition Center Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. General Nutrition Center Recent Developments
Table 116. Blackmores Corporation Information
Table 117. Blackmores Description and Major Businesses
Table 118. Blackmores Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 119. Blackmores Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Blackmores Recent Developments
Table 121. Thompson's Corporation Information
Table 122. Thompson's Description and Major Businesses
Table 123. Thompson's Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 124. Thompson's Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Thompson's Recent Developments
Table 126. BY-HEALTH Corporation Information
Table 127. BY-HEALTH Description and Major Businesses
Table 128. BY-HEALTH Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 129. BY-HEALTH Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. BY-HEALTH Recent Developments
Table 131. Healthy Care Corporation Information
Table 132. Healthy Care Description and Major Businesses
Table 133. Healthy Care Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 134. Healthy Care Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Healthy Care Recent Developments
Table 136. Emerald Labs Corporation Information
Table 137. Emerald Labs Description and Major Businesses
Table 138. Emerald Labs Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 139. Emerald Labs Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Emerald Labs Recent Developments
Table 141. FANCL Corporation Corporation Information
Table 142. FANCL Corporation Description and Major Businesses
Table 143. FANCL Corporation Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 144. FANCL Corporation Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. FANCL Corporation Recent Developments
Table 146. Zahler Corporation Information
Table 147. Zahler Description and Major Businesses
Table 148. Zahler Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 149. Zahler Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Zahler Recent Developments
Table 151. VitaTree Corporation Information
Table 152. VitaTree Description and Major Businesses
Table 153. VitaTree Antiallergic Non-Drug Supplements Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 154. VitaTree Antiallergic Non-Drug Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. VitaTree Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Antiallergic Non-Drug Supplements Distributors List
Table 159. Antiallergic Non-Drug Supplements Customers List
Table 160. Antiallergic Non-Drug Supplements Market Trends
Table 161. Antiallergic Non-Drug Supplements Market Drivers
Table 162. Antiallergic Non-Drug Supplements Market Challenges
Table 163. Antiallergic Non-Drug Supplements Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiallergic Non-Drug Supplements Product Picture
Figure 3. Global Antiallergic Non-Drug Supplements Market Share by Type in 2021 & 2028
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Liquids Product Picture
Figure 6. Global Antiallergic Non-Drug Supplements Market Share by Application in 2021 & 2028
Figure 7. Pollen Allergy
Figure 8. Dust Mites Allergy
Figure 9. Others
Figure 10. Antiallergic Non-Drug Supplements Report Years Considered
Figure 11. Global Antiallergic Non-Drug Supplements Sales 2017-2028 (K Bottles)
Figure 12. Global Antiallergic Non-Drug Supplements Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antiallergic Non-Drug Supplements Revenue 2017-2028 (US$ Million)
Figure 14. Global Antiallergic Non-Drug Supplements Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Antiallergic Non-Drug Supplements Sales Market Share by Region (2017-2022)
Figure 16. Global Antiallergic Non-Drug Supplements Sales Market Share by Region (2023-2028)
Figure 17. North America Antiallergic Non-Drug Supplements Sales YoY (2017-2028) & (K Bottles)
Figure 18. North America Antiallergic Non-Drug Supplements Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Antiallergic Non-Drug Supplements Sales YoY (2017-2028) & (K Bottles)
Figure 20. Europe Antiallergic Non-Drug Supplements Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Antiallergic Non-Drug Supplements Sales YoY (2017-2028) & (K Bottles)
Figure 22. Asia-Pacific Antiallergic Non-Drug Supplements Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Antiallergic Non-Drug Supplements Sales YoY (2017-2028) & (K Bottles)
Figure 24. Latin America Antiallergic Non-Drug Supplements Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Antiallergic Non-Drug Supplements Sales YoY (2017-2028) & (K Bottles)
Figure 26. Middle East & Africa Antiallergic Non-Drug Supplements Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Antiallergic Non-Drug Supplements Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Antiallergic Non-Drug Supplements in the World: Market Share by Antiallergic Non-Drug Supplements Revenue in 2021
Figure 29. Global Antiallergic Non-Drug Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
Figure 31. Global Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
Figure 32. Global Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
Figure 33. Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
Figure 34. North America Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
Figure 35. North America Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
Figure 36. North America Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
Figure 37. North America Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
Figure 38. North America Antiallergic Non-Drug Supplements Sales Share by Country (2017-2028)
Figure 39. North America Antiallergic Non-Drug Supplements Revenue Share by Country (2017-2028)
Figure 40. U.S. Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
Figure 43. Europe Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
Figure 44. Europe Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
Figure 45. Europe Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
Figure 46. Europe Antiallergic Non-Drug Supplements Sales Share by Country (2017-2028)
Figure 47. Europe Antiallergic Non-Drug Supplements Revenue Share by Country (2017-2028)
Figure 48. Germany Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 49. France Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Antiallergic Non-Drug Supplements Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Antiallergic Non-Drug Supplements Revenue Share by Region (2017-2028)
Figure 59. China Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 62. India Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
Figure 70. Latin America Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
Figure 72. Latin America Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Antiallergic Non-Drug Supplements Sales Share by Country (2017-2028)
Figure 74. Latin America Antiallergic Non-Drug Supplements Revenue Share by Country (2017-2028)
Figure 75. Mexico Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Antiallergic Non-Drug Supplements Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Antiallergic Non-Drug Supplements Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Antiallergic Non-Drug Supplements Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Antiallergic Non-Drug Supplements Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Antiallergic Non-Drug Supplements Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Antiallergic Non-Drug Supplements Revenue Share by Country (2017-2028)
Figure 84. Turkey Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Antiallergic Non-Drug Supplements Revenue (2017-2028) & (US$ Million)
Figure 87. Antiallergic Non-Drug Supplements Value Chain
Figure 88. Antiallergic Non-Drug Supplements Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
